Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Long term follow-up of the STOPAGO study

Blood blood.2024025707.

https://doi.org/10.1182/blood.2024025707

Published: 2024

Includes: Supplemental data

Journal Articles

Efficacy and Safety of Dapsone in Primary Immune Thrombocytopenia. Results of a Randomized, Placebo-Controlled Multicenter Trial and of a Single-Arm, Emulated Trial in the Prospective, Multicenter Carmen-France Registry

Marion Larue, Guillaume Moulis, Manuela Rueter, Sylvain Audia, Louis Terriou, Jean-Francois Viallard, Brigitte Pan Petesch, Bruno Royer, Bernard Bonnotte, Lionel Galicier, Olivier Lambotte, Francois Lefrere, Stephane Cheze, Mikael Ebbo, Orianne Wagner-Ballon, Matthieu Mahevas, Bertrand Godeau, Marc Michel

Blood (2023) 142 (Supplement 1): 3983.

https://doi.org/10.1182/blood-2023-181606

Published: 2023

Journal Articles

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Blood (2023) 141 (23): 2867–2877.

https://doi.org/10.1182/blood.2022018665

Published: 2023

Includes: Supplemental data

Journal Articles

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

Blood (2023) 141 (1): 11–21.

https://doi.org/10.1182/blood.2022017277

Published: 2023

Includes: Supplemental data

Journal Articles

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

Blood (2021) 138 (Supplement 1): 583.

https://doi.org/10.1182/blood-2021-152767

Published: 2021

Journal Articles

French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up

Blood (2019) 134 (Supplement_1): 1537.

https://doi.org/10.1182/blood-2019-127560

Published: 2019

Journal Articles

Immunological Cytopenias Induced By Anti-Programmed Cell Death (ligand) 1 Antibodies

Blood (2018) 132 (Supplement 1): 2412.

https://doi.org/10.1182/blood-2018-99-110875

Published: 2018

Journal Articles

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Federico Simonetta, MD PhD, Hélène Labussière-Wallet, MD, Maciej J Machaczka, MD, Flore Sicre de Fontbrune, MD, Michael Medinger, MD, Sylvain Chantepie, MD, Tony Marchand, MD, Stavroula Masouridi-Levrat, MD, Marie-Thérèse Rubio, MD PhD, Oumedaly Reman, MD, Nathalie Dhedin, MD, Loic Fouillard, MD, Olivier Lambotte, MD PhD, Lionel Galicier, MD, Paul Coppo, MD PhD, Jakob Passweg, MD, Ibrahim Yakoub-Agha, MD PhD, Regis Peffault De Latour, MD PhD, Yves Chalandon, MD

Blood (2016) 128 (22): 4617.

https://doi.org/10.1182/blood.V128.22.4617.4617

Published: 2016

Journal Articles

Can Rituximab be Useful for Treating SLE-Associated Immune Cytopenias ? Results from a Retrospective Multicentre Study on 62 Patients

Alexandra Serris, MD, Zahir Amoura, MD MSc, Benjamin Terrier, MD PhD, Eric Hachulla, MD PhD, Nathalie Costedoat-Chalumeau, MD PhD, Thomas Papo, MD, Olivier Lambotte, MD PhD, David Saadoun, MD PhD, Miguel Hie, MD, Philippe Blanche, Corinne Haioun, MD, Bertrand Lioger, Bertrand Godeau, MD PhD, Marc Michel, MD

Blood (2016) 128 (22): 870.

https://doi.org/10.1182/blood.V128.22.870.870

Published: 2016

Journal Articles

Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia

Blood (2016) 128 (12): 1625–1630.

https://doi.org/10.1182/blood-2016-03-704734

Published: 2016

Journal Articles

A Multicenter, Case-Control Study Evaluating the Characteristics and Outcome of ITP Patients Refractory to, Rituximab, Splenectomy and Both TPO Receptor Agonists

Blood (2015) 126 (23): 3460.

https://doi.org/10.1182/blood.V126.23.3460.3460

Published: 2015

Journal Articles

Characteristics and Outcome of HIV Associated Classical Hodgkin's Lymphoma Among 68 Patients Included in the French ANRS CO16 Lymphovir Cohort Study

Blood (2014) 124 (21): 2954.

https://doi.org/10.1182/blood.V124.21.2954.2954

Published: 2014

Journal Articles

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

Blood (2014) 124 (22): 3228–3236.

https://doi.org/10.1182/blood-2014-06-582346

Published: 2014

Journal Articles

Safety and Efficacy Of Rituximab In adult’s Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux Registry

Blood (2013) 122 (21): 450.

https://doi.org/10.1182/blood.V122.21.450.450

Published: 2013

Journal Articles

Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of ITP Patients Treated with Rituximab

Matthieu Mahévas, Marc Michel, Pauline Patin, Francois Huetz, Marc Descatoire, Nicolas Cagnard, Christine Bole-Feysot, Medhi Khellaf, Lionel Galicier, MD, David Boutboul, Mikael Ebbo, Simon le Gallou, Olivier Fain, Olivier Lambotte, MD, PhD, Corinne Haouin, MD, Philippe Bierling, MD, Bertrand Godeau, MD, Jean-claude Weill, Claude-Agnès Reynaud

Blood (2012) 120 (21): 620.

https://doi.org/10.1182/blood.V120.21.620.620

Published: 2012

Journal Articles

A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation

Blood (2011) 118 (18): 4798–4807.

https://doi.org/10.1182/blood-2011-04-347641

Published: 2011

Journal Articles

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program

Blood (2011) 118 (16): 4338–4345.

https://doi.org/10.1182/blood-2011-03-340166

Published: 2011

Includes: Supplemental data

Journal Articles

Restriction of HIV-1 replication in macrophages and CD4 + T cells from HIV controllers

Asier Sáez-Cirión, Chiraz Hamimi, Anna Bergamaschi, Annie David, Pierre Versmisse, Adeline Mélard, Faroudy Boufassa, Françoise Barré-Sinoussi, Olivier Lambotte, Christine Rouzioux, Gianfranco Pancino, for the ANRS CO18 Cohort

Blood (2011) 118 (4): 955–964.

https://doi.org/10.1182/blood-2010-12-327106

Published: 2011

Includes: Supplemental data

Journal Articles

HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis

Blood (2011) 117 (19): 5142–5151.

https://doi.org/10.1182/blood-2011-01-331306

Published: 2011

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the “real-life” : Result of the French Experience in 72 Adults.

Blood (2009) 114 (22): 3519.

https://doi.org/10.1182/blood.V114.22.3519.3519

Published: 2009

NARROW

Long term follow-up of the STOPAGO study

Efficacy and Safety of Dapsone in Primary Immune Thrombocytopenia. Results of a Randomized, Placebo-Controlled Multicenter Trial and of a Single-Arm, Emulated Trial in the Prospective, Multicenter Carmen-France Registry

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)

French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up

Immunological Cytopenias Induced By Anti-Programmed Cell Death (ligand) 1 Antibodies

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Can Rituximab be Useful for Treating SLE-Associated Immune Cytopenias ? Results from a Retrospective Multicentre Study on 62 Patients

Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia

A Multicenter, Case-Control Study Evaluating the Characteristics and Outcome of ITP Patients Refractory to, Rituximab, Splenectomy and Both TPO Receptor Agonists

Characteristics and Outcome of HIV Associated Classical Hodgkin's Lymphoma Among 68 Patients Included in the French ANRS CO16 Lymphovir Cohort Study

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

Safety and Efficacy Of Rituximab In adult’s Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux Registry

Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of ITP Patients Treated with Rituximab

A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program

Restriction of HIV-1 replication in macrophages and CD4 + T cells from HIV controllers

HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the “real-life” : Result of the French Experience in 72 Adults.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only